ATE541583T1 - Enzym-enthaltendes präparat, verfahren zur herstellung und verwendung - Google Patents

Enzym-enthaltendes präparat, verfahren zur herstellung und verwendung

Info

Publication number
ATE541583T1
ATE541583T1 AT03730062T AT03730062T ATE541583T1 AT E541583 T1 ATE541583 T1 AT E541583T1 AT 03730062 T AT03730062 T AT 03730062T AT 03730062 T AT03730062 T AT 03730062T AT E541583 T1 ATE541583 T1 AT E541583T1
Authority
AT
Austria
Prior art keywords
preparation
composition
enzyme
relates
present
Prior art date
Application number
AT03730062T
Other languages
German (de)
English (en)
Inventor
Ingo Haeberlein
Rainer Guggenberger
Wolfgang Weinmann
Oliver Kappler
Original Assignee
3M Espe Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3M Espe Ag filed Critical 3M Espe Ag
Application granted granted Critical
Publication of ATE541583T1 publication Critical patent/ATE541583T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/488—Aspartic endopeptidases (3.4.23), e.g. pepsin, chymosin, renin, cathepsin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
AT03730062T 2002-08-15 2003-05-16 Enzym-enthaltendes präparat, verfahren zur herstellung und verwendung ATE541583T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10237317A DE10237317B4 (de) 2002-08-15 2002-08-15 Enzymhaltige Zusammensetzung, Verfahren zu deren Herstellung und deren Verwendung
PCT/EP2003/005183 WO2004017988A1 (en) 2002-08-15 2003-05-16 Enzyme containing composition, process of producing said composition and its use

Publications (1)

Publication Number Publication Date
ATE541583T1 true ATE541583T1 (de) 2012-02-15

Family

ID=31501753

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03730062T ATE541583T1 (de) 2002-08-15 2003-05-16 Enzym-enthaltendes präparat, verfahren zur herstellung und verwendung

Country Status (9)

Country Link
US (2) US20060115436A1 (enExample)
EP (2) EP2314307B1 (enExample)
JP (2) JP4571859B2 (enExample)
CN (2) CN101810856B (enExample)
AT (1) ATE541583T1 (enExample)
AU (2) AU2003240667C1 (enExample)
CA (1) CA2490721A1 (enExample)
DE (1) DE10237317B4 (enExample)
WO (1) WO2004017988A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10237317B4 (de) 2002-08-15 2010-04-08 3M Espe Ag Enzymhaltige Zusammensetzung, Verfahren zu deren Herstellung und deren Verwendung
AU2005218748A1 (en) 2004-02-27 2005-09-15 3M Espe Ag Dose delivery system
EP1600141B1 (en) * 2004-05-24 2013-04-17 3M Deutschland GmbH Collagenolytic active enzyme containing compositions for the treatment of dental caries
EP1634948A1 (en) 2004-09-10 2006-03-15 Basf Aktiengesellschaft Means and methods for preventing and/or treating caries
EP1754464A1 (en) * 2005-08-17 2007-02-21 3M Innovative Properties Company Enzyme comprising dental composition
EP1844727A1 (en) 2006-04-12 2007-10-17 3M Innovative Properties Company Dental instrument for removing solely unremineralisable carious dentin
RU2446208C9 (ru) 2006-12-19 2012-11-10 Басф Се Применение и способ профилактики или лечения кариеса, вызванного mutans streptococci, отличных от streptococcus mutans
JP5718636B2 (ja) 2007-03-27 2015-05-13 ノボザイムス アクティーゼルスカブ 安定な酵素溶液及び製造方法
USD588446S1 (en) * 2007-12-12 2009-03-17 Hashim Paul R Tree nail
CA2715266A1 (en) 2008-02-08 2009-08-13 Prothera, Inc. Inhibition and treatment of gastrointestinal biofilms
WO2011104339A1 (en) 2010-02-25 2011-09-01 Novozymes A/S Variants of a lysozyme and polynucleotides encoding same
EP2616483A1 (en) 2010-09-16 2013-07-24 Novozymes A/S Lysozymes
EP2782592B1 (en) 2011-11-25 2017-03-15 Novozymes A/S Polypeptides having lysozyme activity and polynucleotides encoding same
IN2014DN06660A (enExample) 2012-01-23 2015-05-22 Morphosys Ag
EP4083066A3 (en) * 2014-05-30 2023-02-08 New England Biolabs, Inc. Deglycosylation reagents and methods
WO2017140807A1 (en) 2016-02-16 2017-08-24 Monaghan Mushrooms Group Fungal polypeptides having lysozyme activity
US10451599B2 (en) 2016-09-02 2019-10-22 Zepto Life Technology, LLC Methods of isolating and detecting metal ions from proteins
JP7275048B2 (ja) 2017-05-12 2023-05-17 ノボザイムス アクティーゼルスカブ リゾチーム活性を有するポリペプチド、それをコードするポリヌクレオチド並びにその使用及び組成物
US11571367B2 (en) * 2018-04-05 2023-02-07 Terrell F. Pannkuk Composition and method for endodontic debridement
EP4629838A1 (en) 2022-12-08 2025-10-15 Novozymes A/S Polypeptide having lysozyme activity and polynucleotides encoding same

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1265468A (en) * 1917-09-18 1918-05-07 Chresten Torben Madsen Level.
DE1467951A1 (de) * 1963-09-04 1969-02-13 Iptor Pharmazeutische Praepara Proteolytische Enzyme enthaltende Zahnreinigungsmittel
NL148236B (nl) * 1967-07-28 1976-01-15 Merck & Co Inc Werkwijze voor het bereiden van enzym bevattende tand- en mondverzorgingsmiddelen en aldus verkregen gevormde produkten.
BE755331A (fr) * 1969-09-01 1971-02-01 Blendax Werke Schneider Co Produits de soins buccaux et dentaires
DE2309440A1 (de) * 1973-02-26 1974-09-05 Katz Verfahren zum isolieren von lysozym
JPS56106593A (en) * 1980-01-24 1981-08-24 Dainippon Pharmaceut Co Ltd Alkali protease m3
JPS57142910A (en) 1981-02-28 1982-09-03 Sankin Kogyo Kk Water-soluble solid agent for cleaning artificial denture
US4355022A (en) 1981-07-01 1982-10-19 Interon, Inc. Method of dental treatment
JPS58148828A (ja) * 1982-02-27 1983-09-05 Advance Res & Dev Co Ltd 歯根管処理剤並びに同処理用キツト
CA1227132A (fr) * 1983-01-05 1987-09-22 Robert J. Weill Preparation a activite collagenolytique ayant une activite elevee et compositions pharmaceutiques la contenant
US4693888A (en) * 1983-08-11 1987-09-15 Lion Corporation Caries-preventive composition
JPH024710A (ja) 1988-06-23 1990-01-09 Nippon Soda Co Ltd 感染根管及び根尖性歯周組織炎治療用製剤
FR2651433B1 (fr) * 1989-09-07 1994-01-14 Dominique Dana Complexe enzymatique a activite sur le tartre et la carie dentaire.
GB8926904D0 (en) * 1989-11-28 1990-01-17 Unilever Plc Thickening system
JP2566676B2 (ja) 1990-03-28 1996-12-25 株式会社クラレ 歯科用組成物
EP0514520A1 (en) 1990-12-05 1992-11-25 Warner-Lambert Company Enzyme containing denture cleanser
GB9207280D0 (en) * 1992-04-02 1992-05-13 Unilever Plc Skin care method and composition
SE9201628D0 (sv) 1992-05-22 1992-05-22 Phairson Medical Ab Pharmaceutical composition
JP3144102B2 (ja) 1992-12-08 2001-03-12 三菱マテリアル株式会社 歯牙根管消毒剤
US5386024A (en) * 1993-02-10 1995-01-31 Gen-Probe Incorporated Method to prepare nucleic acids from a biological sample using low pH and acid protease
JPH0769854A (ja) * 1993-09-02 1995-03-14 Lion Corp 義歯洗浄剤
JP3396934B2 (ja) * 1993-12-01 2003-04-14 ライオン株式会社 義歯洗浄剤
RU2083215C1 (ru) 1994-05-11 1997-07-10 Петр Григорьевич Сторожук Средство для лечения секреторной недостаточности желудка преимущественно у новорожденных детей - пепсирен
CA2199478A1 (en) * 1994-09-09 1996-03-14 Allan L. Delisle Bacteriophage-encoded enzymes for the treatment and prevention of dental caries and periodontal diseases
US5670132A (en) * 1994-09-20 1997-09-23 Immunomedics, Inc. Modified radioantibody fragments for reduced renal uptake
WO1996029978A1 (en) * 1995-03-28 1996-10-03 Novo Nordisk A/S Oral care compositions
US5625341A (en) 1995-08-31 1997-04-29 Sensormatic Electronics Corporation Multi-bit EAS marker powered by interrogation signal in the eight MHz band
BR9707836A (pt) 1996-03-06 1999-07-27 Novo Nordisk Processos para inibir microorganismo presentes na lavagem de roupas e crescimento microbiano sobre uma superfície dura e para exterminar células microbianas presentes na pele de seres humanos ou de animais nas membranas mucosas nos dentes em ferimentos nas contusoes ou nos olhos ou para inibir o seu crescimento
AU716989B2 (en) 1996-04-16 2000-03-16 Novozymes A/S Compositions for the removal of dental plaque
SE507437C2 (sv) 1996-11-14 1998-06-08 Medi Team Dentalutveckling I G Preparat för användning vid kemisk-mekanisk behandling av kariesangrepp och förfarande för framställning av preparatet
US6287550B1 (en) * 1996-12-17 2001-09-11 The Procter & Gamble Company Animal care system and litter with reduced malodor impression
US6100080A (en) 1996-12-18 2000-08-08 Novo Nordisk A/S Method for enzymatic treatment of biofilm
ATE427966T1 (de) * 1997-02-11 2009-04-15 Immunomedics Inc Stimulation einer immunantwort durch antikírper, welche mit dem alpha-galaktosylepitop markiert sind
EP0964909A1 (en) * 1997-03-07 1999-12-22 The Procter & Gamble Company Cleaning compositions comprising xylan degrading alkaline enzyme and non-plant cell walls degrading enzyme
WO1999002632A1 (en) * 1997-07-09 1999-01-21 The Procter & Gamble Company Cleaning compositions comprising a specific oxygenase
DE29714246U1 (de) * 1997-08-08 1998-12-10 THERA Patent GmbH & Co. KG Gesellschaft für industrielle Schutzrechte, 82229 Seefeld Vorrichtung zum Lagern und Auftragen einer fließfähigen Substanz
JP4727818B2 (ja) 1998-11-09 2011-07-20 ノボザイムス アクティーゼルスカブ オキシドレダクターゼ及びｎ−ヒドロキシアニリド型の増強剤を含む抗微生物組成物
US6521215B2 (en) * 1999-05-28 2003-02-18 Devin Okay Compositions and methods for tooth treatment
JP4175746B2 (ja) * 1999-08-30 2008-11-05 独立行政法人科学技術振興機構 新規な耐熱性コラーゲン分解酵素、前記酵素を産生する新規な微生物および前記酵素の製造方法
DE19955746B4 (de) * 1999-11-19 2004-01-29 3M Espe Ag Oberflächenbehandlungsmittel für Hartgewebe und Verwendung von die Enzymaktivität begrenzenden Mitteln zu dessen Herstellung
DE10034647C1 (de) 2000-07-14 2002-04-04 3M Espe Ag Verfahren zur Durchführung einer Speichelanalyse
JP2002078489A (ja) 2000-09-04 2002-03-19 Daiwa Kasei Kk セリン残基が活性発現に関与する新規酸性プロテアーゼ
DE10056212B4 (de) * 2000-11-13 2005-08-18 3M Espe Ag Vorrichtung zum Lagern und Ausbringen von fließfähigen Zusammensetzungen, Verfahren zur Herstellung und Verwendung der Vorrichtung
US7402416B2 (en) * 2002-05-10 2008-07-22 Colgate-Palmolive Company Antibacterial dentifrice exhibiting antiplaque and breath freshening properties
WO2004000222A2 (en) 2002-06-21 2003-12-31 New Horizons Diagnostics Corporation The use of bacterial phage associated lysing proteins for treating bacterial dental caries
DE10237317B4 (de) 2002-08-15 2010-04-08 3M Espe Ag Enzymhaltige Zusammensetzung, Verfahren zu deren Herstellung und deren Verwendung
WO2004047782A1 (en) 2002-11-22 2004-06-10 Unilever N.V. Oral compositions comprising salts of alkyl hydroxybenzoates
US20040120901A1 (en) 2002-12-20 2004-06-24 Dong Wu Dental compositions including enzymes and methods
EP1600141B1 (en) * 2004-05-24 2013-04-17 3M Deutschland GmbH Collagenolytic active enzyme containing compositions for the treatment of dental caries
EP1754464A1 (en) * 2005-08-17 2007-02-21 3M Innovative Properties Company Enzyme comprising dental composition

Also Published As

Publication number Publication date
AU2010201297B2 (en) 2012-12-13
EP1530481A1 (en) 2005-05-18
EP2314307A1 (en) 2011-04-27
AU2003240667A1 (en) 2004-03-11
US20060115436A1 (en) 2006-06-01
CN101810856A (zh) 2010-08-25
JP2010090164A (ja) 2010-04-22
DE10237317A1 (de) 2004-03-11
US20080213196A1 (en) 2008-09-04
CA2490721A1 (en) 2004-03-04
JP5087611B2 (ja) 2012-12-05
DE10237317B4 (de) 2010-04-08
CN101810856B (zh) 2015-05-13
WO2004017988A1 (en) 2004-03-04
EP2314307B1 (en) 2014-03-12
AU2003240667C1 (en) 2010-07-15
JP2006501225A (ja) 2006-01-12
EP1530481B1 (en) 2012-01-18
JP4571859B2 (ja) 2010-10-27
CN1674930A (zh) 2005-09-28
AU2010201297A1 (en) 2010-04-22
US9050332B2 (en) 2015-06-09

Similar Documents

Publication Publication Date Title
ATE541583T1 (de) Enzym-enthaltendes präparat, verfahren zur herstellung und verwendung
DE60311820D1 (de) Neue verwendung von pyrimidin- oder triazin-2-carbonsäurenitrilen zur behandlung von krankheiten, die mit cysteinproteaseaktivität assoziiert sind, und neue pyridimidin-2-carbonsäurenitrilderivate
ATE242003T1 (de) Enzyme zur behandlung von diabetes mellitus typ i
ATE251176T1 (de) Intermediate zur herstellung von thrombininhibitoren als anticoagulantien
GB0228410D0 (en) Novel Compounds
SE0201980D0 (sv) Novel compounds
NO302474B1 (no) Sakarinderivater, farmasöytisk sammensetning og anvendelse derav
GB2305176B (en) Small molecule inhibitors of rotamase enzyme activity
BR0214035A (pt) Composto
TW225532B (enExample)
ATE396174T1 (de) Hydroxyalkylaminderivate als beta-secretase- inhibitoren und deren verwendung zur behandlung der alzheimerschen krankheit oder ähnlicher krankheiten
ATE342964T1 (de) Rekombinante alpha-l-iduronisase, deren herstellungs- und aufreinigungsverfahren, und behandlung von durch diese hervorgerufene mangelerkrankungen
ATE186305T1 (de) Perfluoroalkyll ketone, inhibitoren von elastase und prozess zur deren herstellung
DE60134995D1 (de) Verfahren und zusammensetzungen, die eine stearoyl-coa desuturase-hscd5 verwenden
EP1432310A4 (en) METHOD FOR TREATING CHRONIC CARDIAC INSUFFICIENCY AND / OR HIGH-CHOLESTEROL ACID RATES WITH 3,5-DITODYTHYROPROPIONIC ACID AND PROCESS FOR PREPARING THE SAME
ATE527261T1 (de) 7-aryl-3,9-diazabicycloä3.3.1ünon-6-en-derivate und ihre verwendung als renin-inhibitoren zur behandlung von bluthochdruck, herz-kreislauf- erkrankungen und nierenkrankheiten
ATE293976T1 (de) Verbindungen enthaltend s-tofisopam sowie verwendung dieser verbindungen zur herstellung eines medikamentes zur behandlung oder prophylaxe von krämpfen und anfällen
ATE333451T1 (de) Verwendung von nitrilenverbindungen als arztneimittel
GB0328900D0 (en) Novel compounds
MXPA04002282A (es) Nuevos compuestos y preparaciones como inhibidores de la catepsina.
DE60313803D1 (de) Cathepsincysteinproteaseinhibitoren und deren verwendung zur behandlung von entzündungen und immunerkrankungen
AU2003271811A8 (en) Novel derivatives of 4,4'-dithiobis-(3-aminobutane-1-sulphonates) and compositions containing same
WO2004024077A3 (en) Novel composition and methods for the treatment of psoriasis
ATE299851T1 (de) Verfahren zur herstellung von zwischenprodukten
DE60227008D1 (de) Neue thiophenacylhydrazinoderivate, verfahren zu deren herstellung, deren verwendung als arzneimittel, pharmazeutische zusammensetzungen und neue anwendungen